Novocaine Returns to Paramount+ Top Ten After Slow Theatrical Run

Novocaine, the 2025 dark take on the superhero genre starring Jack Quaid, has quietly climbed back into Paramount+'s U.S. top ten after a disappointing theatrical run. Released March 14, 2025, the film earned $33.5 million worldwide against an $18 million budget and slipped from its opening weekend No.

1 to fourth following the controversial release of Disney's Snow White remake. Directed by Dan Berk and Robert Olsen, the action comedy also stars Amber Midthunder and Jacob Batalon. A logline reads: "When the girl of his dreams (Amber Midthunder) is kidnapped, everyman Nate (Jack Quaid) turns his inability to feel pain into an unexpected strength in his fight to get her back." Runtime is 110 minutes; writers include Lars Jacobson, and producers are listed as Joby Harold, Tory Tunnell, Drew Simon and Nate Sherry.

United States

novocaine, jack quaid, amber midthunder, jacob batalon, paramount+, theatrical run, snow white, dan berk, robert olsen, box office